-
1
-
-
84862684978
-
Molecular imaging: Love it or lose it
-
Margulis AR. Molecular imaging: love it or lose it. Radiology. 2012;264:5.
-
(2012)
Radiology
, vol.264
, pp. 5
-
-
Margulis, A.R.1
-
2
-
-
35348938216
-
Molecular imaging techniques in body imaging
-
Margolis DJ, Hoffman JM, Herfkens RJ, et al. Molecular imaging techniques in body imaging. Radiology. 2007;245: 333-356.
-
(2007)
Radiology
, vol.245
, pp. 333-356
-
-
Margolis, D.J.1
Hoffman, J.M.2
Herfkens, R.J.3
-
3
-
-
79959799326
-
Fundamentals of PET and PET/CT imaging
-
Basu S, Kwee TC, Surti S, et al. Fundamentals of PET and PET/CT imaging. Ann N Y Acad Sci. 2011;1228:1-18.
-
(2011)
Ann N y Acad Sci
, vol.1228
, pp. 1-18
-
-
Basu, S.1
Kwee, T.C.2
Surti, S.3
-
4
-
-
78649320159
-
Radiopharmaceutical chemistry for positron emission tomography
-
Li Z, Conti PS. Radiopharmaceutical chemistry for positron emission tomography. Adv Drug Deliv Rev. 2010;62:1031-1051.
-
(2010)
Adv Drug Deliv Rev
, vol.62
, pp. 1031-1051
-
-
Li, Z.1
Conti, P.S.2
-
6
-
-
77949541610
-
Dual-modality PET/CT instrumentation-today and tomorrow
-
Lonsdale MN, Beyer T. Dual-modality PET/CT instrumentation-today and tomorrow. Eur J Radiol. 2010;73:452-460.
-
(2010)
Eur J Radiol
, vol.73
, pp. 452-460
-
-
Lonsdale, M.N.1
Beyer, T.2
-
7
-
-
41549158607
-
Positron emission tomography/computed tomography
-
Townsend DW. Positron emission tomography/computed tomography. Semin Nucl Med. 2008;38:152-166.
-
(2008)
Semin Nucl Med
, vol.38
, pp. 152-166
-
-
Townsend, D.W.1
-
8
-
-
44849092884
-
Dual-modality imaging: Combining anatomy and function
-
Townsend DW. Dual-modality imaging: combining anatomy and function. J Nucl Med. 2008;49:938-955.
-
(2008)
J Nucl Med
, vol.49
, pp. 938-955
-
-
Townsend, D.W.1
-
9
-
-
40449093361
-
Recommendations on the use of 18F-FDG PET in oncology
-
Fletcher JW, Djulbegovic B, Soares HP, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49:480-508.
-
(2008)
J Nucl Med
, vol.49
, pp. 480-508
-
-
Fletcher, J.W.1
Djulbegovic, B.2
Soares, H.P.3
-
10
-
-
53749095638
-
Unparalleled contribution of 18F-FDG PET to medicine over 3 decades
-
37N
-
Basu S, Alavi A. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades. J Nucl Med. 2008;49: 17N-21N, 37N.
-
(2008)
J Nucl Med
, vol.49
-
-
Basu, S.1
Alavi, A.2
-
11
-
-
34247230296
-
Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities
-
Surti S, Kuhn A, Werner ME, et al. Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities. J Nucl Med. 2007;48: 471-480.
-
(2007)
J Nucl Med
, vol.48
, pp. 471-480
-
-
Surti, S.1
Kuhn, A.2
Werner, M.E.3
-
12
-
-
40449116151
-
Benefit of time-of-flight in PET: Experimental and clinical results
-
Karp JS, Surti S, Daube-Witherspoon ME, et al. Benefit of time-of-flight in PET: experimental and clinical results. J Nucl Med. 2008;49:462-470.
-
(2008)
J Nucl Med
, vol.49
, pp. 462-470
-
-
Karp, J.S.1
Surti, S.2
Daube-Witherspoon, M.E.3
-
13
-
-
79958037890
-
Focus on time-of-flight PET: The benefits of improved time resolution
-
Conti M. Focus on time-of-flight PET: the benefits of improved time resolution. Eur J Nucl Med Mol Imaging. 2011;38:1147-1157.
-
(2011)
Eur J Nucl Med Mol Imaging
, vol.38
, pp. 1147-1157
-
-
Conti, M.1
-
14
-
-
77956227342
-
Time-of-flight PET/CT using low-activity protocols: Potential implications for cancer therapy monitoring
-
Murray I, Kalemis A, Glennon J, et al. Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring. Eur J Nucl Med Mol Imaging. 2010;37: 1643-1653.
-
(2010)
Eur J Nucl Med Mol Imaging
, vol.37
, pp. 1643-1653
-
-
Murray, I.1
Kalemis, A.2
Glennon, J.3
-
15
-
-
84871281666
-
National survey of patient doses from whole-body FDG-PET examinations in France in 2011
-
doi: 10.1093/rpd/ncs066
-
Etard C, Celier D, Roch P, et al. National survey of patient doses from whole-body FDG-PET examinations in France in 2011. Radiat Prot Dosimetry. 2012. doi: 10.1093/rpd/ncs066.
-
(2012)
Radiat Prot Dosimetry
-
-
Etard, C.1
Celier, D.2
Roch, P.3
-
16
-
-
84860877605
-
Functional oncoimaging techniques with potential clinical applications
-
Kwee TC, Basu S, Saboury B, et al. Functional oncoimaging techniques with potential clinical applications. Front Biosci (Elite Ed). 2012;4:1081-1096.
-
(2012)
Front Biosci (Elite Ed)
, vol.4
, pp. 1081-1096
-
-
Kwee, T.C.1
Basu, S.2
Saboury, B.3
-
17
-
-
34548165833
-
Functional imaging of cancer with emphasis on molecular techniques
-
Torigian DA, Huang SS, Houseni M, et al. Functional imaging of cancer with emphasis on molecular techniques. CA Cancer J Clin. 2007;57:206-224.
-
(2007)
CA Cancer J Clin
, vol.57
, pp. 206-224
-
-
Torigian, D.A.1
Huang, S.S.2
Houseni, M.3
-
18
-
-
0033870513
-
A combined PET/CT scanner for clinical oncology
-
Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369-1379.
-
(2000)
J Nucl Med
, vol.41
, pp. 1369-1379
-
-
Beyer, T.1
Townsend, D.W.2
Brun, T.3
-
19
-
-
60549091544
-
Multimodality imaging: An update on PET/CT technology
-
Mawlawi O, Townsend DW. Multimodality imaging: an update on PET/CT technology. Eur J Nucl Med Mol Imaging. 2009;36(suppl 1):S15-S29.
-
(2009)
Eur J Nucl Med Mol Imaging
, vol.36
, Issue.SUPPL. 1
-
-
Mawlawi, O.1
Townsend, D.W.2
-
20
-
-
77954343920
-
Cancer imaging: Novel concepts in clinical magnetic resonance imaging
-
Kwee TC, Takahara T, Klomp DW, et al. Cancer imaging: novel concepts in clinical magnetic resonance imaging. J Intern Med. 2010;268:120-132.
-
(2010)
J Intern Med
, vol.268
, pp. 120-132
-
-
Kwee, T.C.1
Takahara, T.2
Klomp, D.W.3
-
21
-
-
78649669314
-
Computed tomography and magnetic resonance imaging in cystic fibrosis lung disease
-
Eichinger M, Heussel CP, Kauczor HU, et al. Computed tomography and magnetic resonance imaging in cystic fibrosis lung disease. J Magn Reson Imaging. 2010;32:1370-1378.
-
(2010)
J Magn Reson Imaging
, vol.32
, pp. 1370-1378
-
-
Eichinger, M.1
Heussel, C.P.2
Kauczor, H.U.3
-
22
-
-
34247881892
-
Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI
-
Semelka RC, Armao DM, Elias J Jr, et al. Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI. J Magn Reson Imaging. 2007;25:900-909.
-
(2007)
J Magn Reson Imaging
, vol.25
, pp. 900-909
-
-
Semelka, R.C.1
Armao, D.M.2
Elias Jr., J.3
-
23
-
-
84871739831
-
PET/MRI-Technical aspects and potential clinical applications
-
In press
-
Torigian DA, Zaidi H, Kwee TC, et al. PET/MRI-Technical aspects and potential clinical applications. Radiology. 2012. In press.
-
(2012)
Radiology
-
-
Torigian, D.A.1
Zaidi, H.2
Kwee, T.C.3
-
24
-
-
34548056792
-
Current status of breast MR imaging. Part 2. Clinical applications
-
Kuhl CK. Current status of breast MR imaging. Part 2. Clinical applications. Radiology. 2007;244:672-691.
-
(2007)
Radiology
, vol.244
, pp. 672-691
-
-
Kuhl, C.K.1
-
26
-
-
33750372663
-
Cardiac MR imaging: State of the technology
-
Finn JP, Nael K, Deshpande V, et al. Cardiac MR imaging: state of the technology. Radiology. 2006;241:338-354.
-
(2006)
Radiology
, vol.241
, pp. 338-354
-
-
Finn, J.P.1
Nael, K.2
Deshpande, V.3
-
27
-
-
84864352415
-
Pulmonary lesion assessment: Comparison of whole-Body hybrid MR/PET and PET/CT imaging-pilot study
-
Schwenzer NF, Schraml C, Müller M, et al. Pulmonary lesion assessment: comparison of whole-Body hybrid MR/PET and PET/CT imaging-pilot study. Radiology. 2012;264:551-558.
-
(2012)
Radiology
, vol.264
, pp. 551-558
-
-
Schwenzer, N.F.1
Schraml, C.2
Müller, M.3
-
30
-
-
0033250648
-
MR imaging of the chest: Mediastinum and chest wall
-
Landwehr P, Schulte O, Lackner K. MR imaging of the chest: mediastinum and chest wall. Eur Radiol. 1999;9:1737-1744.
-
(1999)
Eur Radiol
, vol.9
, pp. 1737-1744
-
-
Landwehr, P.1
Schulte, O.2
Lackner, K.3
-
31
-
-
83155165211
-
Preliminary study of whole-body diffusion-weighted imaging in detecting pulmonary metastatic lesions from clear cell renal cell carcinoma: Comparison with CT
-
Liu J, Yang X, Li F, et al. Preliminary study of whole-body diffusion-weighted imaging in detecting pulmonary metastatic lesions from clear cell renal cell carcinoma: comparison with CT. Acta Radiol. 2011;52:954-963.
-
(2011)
Acta Radiol
, vol.52
, pp. 954-963
-
-
Liu, J.1
Yang, X.2
Li, F.3
-
32
-
-
84871747265
-
Ultrashort echo time MRI of lung pathology in humans. in
-
Melbourne, Australia, May 5-10
-
Nagle SK, Nackos JS, Schiebler ML, et al. Ultrashort echo time MRI of lung pathology in humans. In: Presentation of the ISMRM 20th Annual Meeting, Melbourne, Australia, May 5-10, 2012.
-
(2012)
Presentation of the ISMRM 20th Annual Meeting
-
-
Nagle, S.K.1
Nackos, J.S.2
Schiebler, M.L.3
-
33
-
-
84861848020
-
Oncologic PET/MRI, part 1: Tumors of the brain, head and neck, chest, abdomen, and pelvis
-
Buchbender C, Heusner TA, Lauenstein TC, et al. Oncologic PET/MRI, part 1: tumors of the brain, head and neck, chest, abdomen, and pelvis. J Nucl Med. 2012;53:928-938.
-
(2012)
J Nucl Med
, vol.53
, pp. 928-938
-
-
Buchbender, C.1
Heusner, T.A.2
Lauenstein, T.C.3
-
34
-
-
66149106325
-
Standards for PET image acquisition and quantitative data analysis
-
Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med. 2009;50(suppl 1): 11S-20S.
-
(2009)
J Nucl Med
, vol.50
, Issue.SUPPL. 1
-
-
Boellaard, R.1
-
35
-
-
0034086992
-
Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy- Dglucose and positron emission tomography: An overview of different analytical methods
-
Hoekstra CJ, Paglianiti I, Hoekstra OS, et al. Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-Dglucose and positron emission tomography: an overview of different analytical methods. Eur J Nucl Med. 2000;27: 731-743.
-
(2000)
Eur J Nucl Med
, vol.27
, pp. 731-743
-
-
Hoekstra, C.J.1
Paglianiti, I.2
Hoekstra, O.S.3
-
36
-
-
34047192093
-
Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: Implications for normal variation, aging and diseased states
-
Basu S, Zaidi H, Houseni M, et al. Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: Implications for normal variation, aging and diseased states. Semin Nucl Med. 2007;37:223-239.
-
(2007)
Semin Nucl Med
, vol.37
, pp. 223-239
-
-
Basu, S.1
Zaidi, H.2
Houseni, M.3
-
37
-
-
0033737712
-
Anatomy of SUV. Standardized uptake value
-
Huang SC. Anatomy of SUV. Standardized uptake value. Nucl Med Biol. 2000;27:643-646.
-
(2000)
Nucl Med Biol
, vol.27
, pp. 643-646
-
-
Huang, S.C.1
-
38
-
-
0028784446
-
SUV standard uptake or silly useless value?
-
Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med. 1995;36:1836-1839.
-
(1995)
J Nucl Med
, vol.36
, pp. 1836-1839
-
-
Keyes Jr., J.W.1
-
39
-
-
79958066208
-
Suboptimal and inadequate quantification: An alarming crisis in medical applications of PET
-
Basu S, Kwee TC, Torigian D, et al. Suboptimal and inadequate quantification: an alarming crisis in medical applications of PET. Eur J Nucl Med Mol Imaging. 2011;38: 1381-1382.
-
(2011)
Eur J Nucl Med Mol Imaging
, vol.38
, pp. 1381-1382
-
-
Basu, S.1
Kwee, T.C.2
Torigian, D.3
-
40
-
-
77955603274
-
A systematic review of the factors affecting accuracy of SUV measurements
-
Adams MC, Turkington TG, Wilson JM, et al. A systematic review of the factors affecting accuracy of SUV measurements. Am J Roentgenol. 2010;195:310-320.
-
(2010)
Am J Roentgenol
, vol.195
, pp. 310-320
-
-
Adams, M.C.1
Turkington, T.G.2
Wilson, J.M.3
-
41
-
-
79955364625
-
Feasibility and performance of novel software to quantify metabolically active volumes and 3D partial volume corrected SUV and metabolic volumetric products of spinal bone marrow metastases on 18FFDG-PET/CT
-
Torigian DA, Lopez RF, Alapati S, et al. Feasibility and performance of novel software to quantify metabolically active volumes and 3D partial volume corrected SUV and metabolic volumetric products of spinal bone marrow metastases on 18FFDG-PET/CT. Hell J Nucl Med. 2011;14:8-14.
-
(2011)
Hell J Nucl Med
, vol.14
, pp. 8-14
-
-
Torigian, D.A.1
Lopez, R.F.2
Alapati, S.3
-
42
-
-
0032757213
-
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: Review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group
-
Young H, Baum R, Cremerius U, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer. 1999;35:1773-1782.
-
(1999)
Eur J Cancer
, vol.35
, pp. 1773-1782
-
-
Young, H.1
Baum, R.2
Cremerius, U.3
-
43
-
-
66149139452
-
From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors
-
Wahl RL, Jacene H, Kasamon Y, et al. From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(suppl 1):122S-150S.
-
(2009)
J Nucl Med
, vol.50
, Issue.SUPPL. 1
-
-
Wahl, R.L.1
Jacene, H.2
Kasamon, Y.3
-
44
-
-
79957526789
-
Cancer response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST
-
Costelloe CM, Chuang HH, Madewell JE, et al. Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST. J Cancer. 2010;1:80-92.
-
(2010)
J Cancer
, vol.1
, pp. 80-92
-
-
Costelloe, C.M.1
Chuang, H.H.2
Madewell, J.E.3
-
45
-
-
57849117384
-
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
-
Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228-247.
-
(2009)
Eur J Cancer
, vol.45
, pp. 228-247
-
-
Eisenhauer, E.A.1
Therasse, P.2
Bogaerts, J.3
-
46
-
-
84861872570
-
Evaluation of response to neoadjuvant chemotherapy for esophageal cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors
-
Yanagawa M, Tatsumi M, Miyata H, et al. Evaluation of response to neoadjuvant chemotherapy for esophageal cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors. J Nucl Med. 2012;53: 872-880.
-
(2012)
J Nucl Med
, vol.53
, pp. 872-880
-
-
Yanagawa, M.1
Tatsumi, M.2
Miyata, H.3
-
47
-
-
0027482523
-
Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: Atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators
-
Alavi A, Newberg AB, Souder E, et al. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J Nucl Med. 1993;34:1681-1687.
-
(1993)
J Nucl Med
, vol.34
, pp. 1681-1687
-
-
Alavi, A.1
Newberg, A.B.2
Souder, E.3
-
48
-
-
0000827344
-
Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis
-
Larson SM, Erdi Y, Akhurst T, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging. 1999;2:159-171.
-
(1999)
Clin Positron Imaging
, vol.2
, pp. 159-171
-
-
Larson, S.M.1
Erdi, Y.2
Akhurst, T.3
-
49
-
-
33751208879
-
Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: A new concept
-
Bural GG, Torigian DA, Chamroonrat W, et al. Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept. Nucl Med Biol. 2006;33:1037-1043.
-
(2006)
Nucl Med Biol
, vol.33
, pp. 1037-1043
-
-
Bural, G.G.1
Torigian, D.A.2
Chamroonrat, W.3
-
50
-
-
77956706071
-
Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: A novel concept
-
Bural GG, Torigian DA, Burke A, et al. Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept. Mol Imaging Biol. 2010;12:233-239.
-
(2010)
Mol Imaging Biol
, vol.12
, pp. 233-239
-
-
Bural, G.G.1
Torigian, D.A.2
Burke, A.3
-
51
-
-
84855653918
-
Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: Emerging significance of image segmentation and global disease assessment
-
Basu S, Saboury B, Torigian DA, et al. Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment. Mol Imaging Biol. 2011;13:801-811.
-
(2011)
Mol Imaging Biol
, vol.13
, pp. 801-811
-
-
Basu, S.1
Saboury, B.2
Torigian, D.A.3
-
52
-
-
84857157157
-
Automatic volume delineation in oncological PET. Evaluation of a dedicated software tool and comparison with manual delineation in clinical data sets
-
Hofheinz F, Potzsch C, Oehme L, et al. Automatic volume delineation in oncological PET. Evaluation of a dedicated software tool and comparison with manual delineation in clinical data sets. Nuklearmedizin. 2012;51:9-16.
-
(2012)
Nuklearmedizin
, vol.51
, pp. 9-16
-
-
Hofheinz, F.1
Potzsch, C.2
Oehme, L.3
-
53
-
-
79955396137
-
Quantitative 3D ROI delineation in PET: Algorithm and validation
-
Hofheinz F, Pötzsch C, van den Hoff J. Quantitative 3D ROI delineation in PET: algorithm and validation. J Nucl Med. 2007;48:407P.
-
(2007)
J Nucl Med
, vol.48
, pp. 407
-
-
Hofheinz, F.1
Pötzsch, C.2
Van Den Hoff, J.3
-
54
-
-
34250315240
-
Partial-volume effect in PET tumor imaging
-
Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932-945.
-
(2007)
J Nucl Med
, vol.48
, pp. 932-945
-
-
Soret, M.1
Bacharach, S.L.2
Buvat, I.3
-
55
-
-
0033955723
-
Recovery correction for quantitation in emission tomography: A feasibility study
-
Geworski L, Knoop BO, de Cabrejas ML, et al. Recovery correction for quantitation in emission tomography: a feasibility study. Eur J Nucl Med. 2000;27:161-169.
-
(2000)
Eur J Nucl Med
, vol.27
, pp. 161-169
-
-
Geworski, L.1
Knoop, B.O.2
De Cabrejas, M.L.3
-
56
-
-
0036454017
-
Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDGPET
-
Hickeson M, Yun M, Matthies A, et al. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDGPET. Eur J Nucl Med Mol Imaging. 2002;29:1639-1647.
-
(2002)
Eur J Nucl Med Mol Imaging
, vol.29
, pp. 1639-1647
-
-
Hickeson, M.1
Yun, M.2
Matthies, A.3
-
57
-
-
0036771850
-
110mIn-DTPA-D-Phe1-octreotide for imaging of neuroendocrine tumors with PET
-
Lubberink M, Tolmachev V, Widström C, et al. 110mIn-DTPA-D-Phe1- octreotide for imaging of neuroendocrine tumors with PET. J Nucl Med. 2002;43:1391-1397.
-
(2002)
J Nucl Med
, vol.43
, pp. 1391-1397
-
-
Lubberink, M.1
Tolmachev, V.2
Widström, C.3
-
58
-
-
67651177441
-
A recovery coefficient method for partial volume correction of PET images
-
Srinivas SM, Dhurairaj T, Basu S, et al. A recovery coefficient method for partial volume correction of PET images. Ann Nucl Med. 2009;23:341-348.
-
(2009)
Ann Nucl Med
, vol.23
, pp. 341-348
-
-
Srinivas, S.M.1
Dhurairaj, T.2
Basu, S.3
-
59
-
-
77956188828
-
Partial volume correction strategies for quantitative FDG PET in oncology
-
Hoetjes NJ, van Velden FH, Hoekstra OS, et al. Partial volume correction strategies for quantitative FDG PET in oncology. Eur J Nucl Med Mol Imaging. 2010;37:1679-1687.
-
(2010)
Eur J Nucl Med Mol Imaging
, vol.37
, pp. 1679-1687
-
-
Hoetjes, N.J.1
Van Velden, F.H.2
Hoekstra, O.S.3
-
60
-
-
84871777673
-
A method for model-free partial volume correction in oncological PET
-
Hofheinz F, Langner J, Petr J, et al. A method for model-free partial volume correction in oncological PET. EJNMMI Res. 2012;2:16.
-
(2012)
EJNMMI Res
, vol.2
, pp. 16
-
-
Hofheinz, F.1
Langner, J.2
Petr, J.3
|